生物药物 SCIE

期刊简介预计审稿时间： 12周，或约稿

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

对生物疗法感兴趣的研发专业人员和临床医生的重要资源。

BioDrugs 涵盖了用于治疗人类疾病的生物技术药物和诊断产品的开发和治疗应用。

BioDrugs 提供了一系列额外的增强功能，旨在提高期刊内容的可见性、读者群和教育价值。每篇文章都附有要点摘要，为广大读者提供内容的省时概述。文章可能附有通俗易懂的语言摘要，以帮助患者、护理人员和其他人了解重要的医学进展。该期刊还提供包括幻灯片集、视频和动画等各种其他类型的增强功能的选项。所有增强功能都经过同行评审，标准与文章本身一样高。同行评审使用 Editorial Manager® 进行，由国际专家数据库支持。该数据库与其他 Adis 期刊共享。

《Biodrugs》(生物药物)编辑部通讯方式为ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。